AN Frickenstein, JM Hagood, CN Britten, BS Abbott… - Pharmaceutics, 2021 - mdpi.com
Due to the theragnostic potential of mesoporous silica nanoparticles (MSNs), these were
extensively investigated as a novel approach to improve clinical outcomes. Boasting an …